Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
08/2002
08/29/2002WO2002066457A1 BENZO[b]THIOPHENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME
08/29/2002WO2002066456A2 Thiophene substituted amine derivatives as glyt-1 inhibitors
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002WO2002000641A3 Spla2 inhibitors
08/29/2002WO2001012584A3 Pharmaceutical compounds
08/29/2002WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/29/2002WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002DE19941540C2 Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie Sulfonylcarboxamide for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia
08/29/2002CA2438367A1 Thiophene substituted amine derivatives as glyt-1 inhibitors
08/29/2002CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438316A1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/28/2002EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002EP1233958A1 Inhibitors of histone deacetylase
08/28/2002EP1233957A1 Novel amidine derivatives, preparation and use thereof as medicines
08/28/2002EP1233952A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides
08/28/2002EP0993445B1 New oxime sulfonates and the use thereof as latent sulfonic acids
08/28/2002EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
08/28/2002EP0531475B1 Naphthyl organic compounds
08/28/2002CN1089764C Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same
08/28/2002CN1089749C Pesticidal hydrazide derivatives
08/27/2002US6441246 Using dehydration agent
08/27/2002US6441244 Benzophenones and the use thereof as photoinitiators
08/27/2002US6441195 Substituted sulphonylamino(thio) carbonyl compounds
08/27/2002US6441185 Method for producing thiazolidinediones, and new thiazolidinediones
08/27/2002US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity
08/27/2002US6441169 Pyrimidin-2-oxy-4-one and pyrimidin-2-oxy-4-thione derivatives
08/27/2002US6441049 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods
08/27/2002CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them
08/22/2002WO2002064588A1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
08/22/2002WO2002064565A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
08/22/2002WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals
08/22/2002WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/22/2002WO2002038557A3 Benzoylbenzofurane derivatives for treatment of cardiac arrhythmia
08/22/2002US20020115871 Reacting an amino alcohol with a benzothiophene, reacting the product with a halo oxacid in the presence of 2,2,6,6-tetra methylpiperidine-1-oxyls, further reacting with an ylide under wittig reaction conditions and deprotecting
08/22/2002US20020115870 Heterarylbenzene compounds
08/22/2002US20020115864 Potentiators of glutamate receptor function
08/22/2002US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects
08/22/2002US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
08/22/2002US20020114973 Molecular compound, luminous material using the same, and luminous element
08/22/2002US20020114770 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits
08/22/2002DE10114425C1 Diaminobenzol-Derivate und diese Verbindungen enthaltende Haarfärbemittel Diaminobenzene derivatives and compositions containing these compounds hair dye
08/21/2002EP1232152A1 Improved process for preparing nitrogen-substituted aminotetralins
08/21/2002EP1232150A1 Urea derivatives as anti-inflammatory agents
08/21/2002EP1231939A2 Oncolytic combinations for the treatment of cancer
08/21/2002EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
08/21/2002EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
08/21/2002CN1365347A Anthracene derivatives and organic electroleuminescents device made by using the same
08/21/2002CN1089437C Neutral molecular detection method and device including using new compound and painting materials
08/21/2002CN1089237C Compound for use in preparing medium for inhibiting vascular smooth muscle cell migration
08/20/2002US6437144 Methods for the preparation of 4-hydroxy benzothiophene
08/20/2002US6436958 Inhibition of t cell function and class ii antigen expression thereby inhibiting macrophage mediated antigen presentation, and/or inhibition of release of il-1, tnf cytokines, and other inflammatory mediators; 2-phenyl-3-aroylbenzothiophenes
08/20/2002US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/20/2002CA2077695C Hydropyridine derivatives having antithrombotic activity
08/15/2002WO2002062783A1 Dyes for keratin fibres containing 1,3-diamino-4-heteroarylbenzene derivatives and novel 1,3-diamino-4-heteroarylbenzene derivatives
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062750A1 Cannabinoid receptor ligands
08/15/2002WO2002062332A1 Pharmaceutical composition for treating multiple sclerosis
08/15/2002WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties
08/15/2002WO2001072685B1 Polyamine analogues as cytotoxic agents
08/15/2002US20020111273 Insecticides, fungicides, miticides, plant safening agents
08/15/2002US20020110650 Photostability; absorption; optical recording materials
08/15/2002CA2437405A1 Potassium channel openers
08/15/2002CA2436433A1 Dyes for keratin fibres containing 1,3-diamino-4-heteroarylbenzene derivatives and novel 1,3-diamino-4-heteroarylbenzene derivatives
08/14/2002EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/14/2002EP0790974B1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
08/14/2002EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors
08/14/2002DE10106457A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines
08/14/2002DE10103506A1 Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose A pharmaceutical composition for the treatment of Multiple Sclerosis
08/14/2002CN1364162A Alpha-phenyl-beta-ketosulfone
08/14/2002CN1364155A N-Cyanomethyl amides as protease inhibitors
08/13/2002US6433172 Cardiovascular disorders; hypotensive agents; anticholesterol agents
08/13/2002US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents
08/13/2002US6433005 Selective cox ii inhibitor
08/13/2002US6432995 Inhibit the release of inflammatory cytokines such as interleukin-1 and tumor necrosis factor from cells
08/13/2002US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents
08/13/2002US6432983 Treating estrogen-dependent cancer, endometriosis, osteoporosis, post-menopausal disorders and hyperlipidemia; restenosis inhibitors
08/13/2002US6432982 Benzothiophenes, and formulations and methods using same
08/13/2002US6432949 Amide derivatives useful as inhibitors of the production of cytokines
08/13/2002US6432947 N-heterocyclic derivatives as NOS inhibitors
08/13/2002US6432656 Detection of calcilytic compound for calcium receptor bearing cell
08/13/2002CA2039120C Complexes of tiaprofenic acid, or of its insoluble or partly insoluble esters, with cyclodextrines or their derivatives
08/08/2002WO2002060885A1 Chemical compounds
08/08/2002WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
08/08/2002WO2002060858A1 Novel compound having maillard reaction inhibitory activity
08/08/2002WO2002018327A3 Guanidinobenzamides as mc4-r agonists
08/08/2002WO2002006189A3 Aniline derivatives
08/08/2002WO2002002518A3 Compounds to treat alzheimer's disease